FDA Issues Warnings for Some OTC Topical Pain Relievers
The FDA has issued consumer warnings regarding certain over-the-counter topical pain relievers that contain excessive amounts of lidocaine.
The FDA has issued consumer warnings regarding certain over-the-counter topical pain relievers that contain excessive amounts of lidocaine.
We present the case of Mr. B, who was part of a NIMH-funded, longitudinal, observational study (2013 to 2016) that recruited unmedicated participants who were…
This systematic review and meta-analysis assesses the prevalence of mental health disorders among people experiencing homelessness.
JCP published research that explores the impact of tardive dyskinesia on patients, a new diagnostic tool, and the effect of LAI-APs.
An expert explains the mechanism, risk factors, progression, and quality of life implications of Tardive Dyskinesia.
This study evaluated real-world treatment patterns for patients initiating benztropine and examined treatment approaches in patients with drug-induced movement disorders from a health care provider…
The grant coincides with Mental Health Awareness Month coming up in May.
Over the past year, my presidential theme has been “Confronting Addiction From Prevention to Recovery.” This initiative has focused on four of the biggest areas…
This Viewpoint advocates for the addition of clozapine prescribing as a milestone in psychiatric education.
JAACAP Connect emphasizes translation of child and adolescent psychiatry research into clinical practice.
Forty-three percent of U.S. adults said that they feel more anxious now than they did last year, compared with 37% in 2023 and 32% in…